Canada Medical Devices & Instruments Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Medical Devices & Instruments
Bausch + Lomb Surges Amid Potential Buyout by TPG and Blackstone
Oct 14, 2024 ★★★☆☆
Medical Devices & Instruments
Profound Medical Corp (PROF) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Rising Expenses
Profound Medical Corp (PROF) reports a 39% revenue increase in Q2 2024, driven by recurring sources, despite challenges in profitability and reimbursement transitions. Oct 09, 2024
Medical Devices & Instruments
Aurora Spine Corp (ASAPF) Q2 2024 Earnings Call Transcript Highlights: Revenue Growth and Margin Improvement Amid Operational Challenges
Aurora Spine Corp (ASAPF) reports a 14% revenue increase and significant margin improvement, despite facing higher operating expenses and ongoing market challenges. Aug 24, 2024
Medical Devices & Instruments
Theralase Technologies Inc (TLTFF) Q2 2024 Earnings Call Transcript Highlights: Revenue Decline and Strategic Financing Initiatives
Theralase Technologies Inc (TLTFF) reports a 30.5% revenue decrease but shows progress in clinical studies and financing efforts. Aug 22, 2024